Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis
- PMID: 11474495
- DOI: 10.1002/ijc.1020
Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis
Abstract
CD95 (Fas/APO-1) is a death receptor on the surface of a wide variety of cell types. In most cells examined, ionizing radiation acts as a response-enhancing agent for CD95-mediated cell death. Although DNA-damaging radiation appears to modulate CD95-mediated signals through multiple mechanisms, the only well-characterized mechanism is activation of the tumor-suppressor protein p53, which transcriptionally regulates the expression of CD95 on various cell types. The ligand for CD95 is expressed by activated lymphocytes and natural-killer cells, which produce factors that sensitize cells resistant to CD95-mediated cell death. Ligation of CD95 on irradiated tumor cells might be achievable using emerging modalities that reactivate the stalled anti-tumor immune response.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.J Immunol. 2003 Aug 1;171(3):1172-82. doi: 10.4049/jimmunol.171.3.1172. J Immunol. 2003. PMID: 12874203
-
Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells.Br J Haematol. 1997 Jan;96(1):147-57. doi: 10.1046/j.1365-2141.1997.8742505.x. Br J Haematol. 1997. PMID: 9012700
-
CD95/Fas signaling in T lymphocytes induces the cell cycle control protein p21cip-1/WAF-1, which promotes apoptosis.J Immunol. 2000 Apr 15;164(8):4032-6. doi: 10.4049/jimmunol.164.8.4032. J Immunol. 2000. PMID: 10754295
-
CD95-mediated cell signaling in cancer: mutations and post-translational modulations.Cell Mol Life Sci. 2012 Apr;69(8):1261-77. doi: 10.1007/s00018-011-0866-4. Epub 2011 Nov 1. Cell Mol Life Sci. 2012. PMID: 22042271 Free PMC article. Review.
-
CD95 signaling in cancer treatment.Curr Pharm Des. 2014;20(17):2809-18. doi: 10.2174/13816128113199990589. Curr Pharm Des. 2014. PMID: 23944368 Review.
Cited by
-
Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored.Front Immunol. 2014 Mar 14;5:102. doi: 10.3389/fimmu.2014.00102. eCollection 2014. Front Immunol. 2014. PMID: 24672524 Free PMC article. Review.
-
Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma.J Immunother. 2008 Nov-Dec;31(9):885-95. doi: 10.1097/CJI.0b013e3181880f1e. J Immunother. 2008. PMID: 18832999 Free PMC article.
-
CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.Blood. 2006 Nov 15;108(10):3450-7. doi: 10.1182/blood-2006-04-017749. Epub 2006 Jun 1. Blood. 2006. PMID: 16741250 Free PMC article.
-
Combining radiotherapy and immunotherapy: a revived partnership.Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):655-66. doi: 10.1016/j.ijrobp.2005.06.032. Int J Radiat Oncol Biol Phys. 2005. PMID: 16199306 Free PMC article. Review.
-
Transcriptional response of lymphoblastoid cells to ionizing radiation.Genome Res. 2003 Sep;13(9):2092-100. doi: 10.1101/gr.1240103. Epub 2003 Aug 12. Genome Res. 2003. PMID: 12915489 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous